186
Views
29
CrossRef citations to date
0
Altmetric
Original Article: Research

Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1

, , , , , & show all
Pages 1184-1189 | Received 11 Feb 2008, Accepted 16 Mar 2008, Published online: 01 Jul 2009

References

  • Goodwin G H, Sanders C, Johns E W. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 1973; 38: 14–19
  • Parkkinen J, Raulo E, Merenmies J, Nolo R, Kajander E O, Baumann M, Rauvala H. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993; 268: 19726–19738
  • Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001; 152: 1197–1206
  • Wang H, Bloom O, Zhang M, Vishnubhakat J M, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248–251
  • Gratzinger D, Zhao S, Marinelli R J, Kapp A V, Tibshirani R J, Hammer A S, et al. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. Am J Pathol 2007; 170: 1362–1369
  • Schlueter C, Weber H, Meyer B, Rogalla P, Roser K, Hauke S, Bullerdiek J. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 2005; 166: 1259–1263
  • Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 2006; 176: 12–15
  • Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S, Ohmori H. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol 2005; 166: 751–760
  • Taguchi A, Blood D C, del Toro G, Canet A, Lee D C, Qu W, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000; 405: 354–360
  • Zeh H J, 3rd, Lotze M T. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 2005; 28: 1–9
  • Antonov J, Goldstein D R, Oberli A, Baltzer A, Pirotta M, Fleischmann A, et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 2005; 85: 1040–1050
  • Rogalla P, Kazmierczak B, Flohr A M, Hauke S, Bullerdiek J. Back to the roots of a new exon – the molecular archaeology of a SP100 splice variant. Genomics 2000; 63: 117–122
  • Strichman-Almashanu L Z, Bustin M, Landsman D. Retroposed copies of the HMG genes: a window to genome dynamics. Genome Res 2003; 13: 800–812
  • Rauvala H, Huttunen H J, Fages C, Kaksonen M, Kinnunen T, Imai S, et al. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol 2000; 19: 377–387
  • van Beijnum J R, Dings R P, van der Linden E, Zwaans B M, Ramaekers F C, Mayo K H, et al. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood 2006; 108: 2339–2348
  • Volp K, Brezniceanu M L, Bosser S, Brabletz T, Kirchner T, Gottel D, et al. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 2006; 55: 234–242
  • Yu J, Mallon M A, Zhang W, Freimuth R R, Marsh S, Watson M A, et al. DNA repair pathway profiling and microsatellite instability in colorectal cancer. Clin Cancer Res 2006; 12: 5104–5111
  • Xiang Y Y, Wang D Y, Tanaka M, Suzuki M, Kiyokawa E, Igarashi H, et al. Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa. Int J Cancer 1997; 74: 1–6
  • Oue N, Aung P P, Mitani Y, Kuniyasu H, Nakayama H, Yasui W. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 2005; 69(Suppl 1)17–22
  • Flohr A M, Rogalla P, Meiboom M, Borrmann L, Krohn M, Thode-Halle B, et al. Variation of HMGB1 expression in breast cancer. Anticancer Res 2001; 21: 3881–3885
  • Brezniceanu M L, Volp K, Bosser S, Solbach C, Lichter P, Joos S, et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. Faseb J 2003; 17: 1295–1297
  • Kawahara N, Tanaka T, Yokomizo A, Nanri H, Ono M, Wada M, et al. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. Cancer Res 1996; 56: 5330–5333
  • Kuniyasu H, Chihara Y, Kondo H, Ohmori H, Ukai R. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer. Oncol Rep 2003; 10: 1863–1868
  • Poser I, Golob M, Buettner R, Bosserhoff A K. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol 2003; 23: 2991–2998
  • Scaffidi P, Misteli T, Bianchi M E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191–195
  • Zhang C L, Shu M G, Qi H W, Li L W. Inhibition of tumor angiogenesis by HMGB1 A box peptide. Med Hypotheses 2008; 70: 343–345

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.